https://www.selleckchem.com/pr....oducts/brincidofovir
Observed 30-day readmissions of 24% were identical for SLE and HF (p=0.6), and higher than other Medicare (16%, p0.001). Both SLE and HF had elevated readmission risk (ARR 1.08, (95% CI (1.04, 1.13)); 1.11, (1.09, 1.13)). SLE readmissions were higher for Black (30%) versus White (21%) populations, and highest in ages 18-33 (39%) and ESRD (37%). Admissions of Black patients with SLE from least disadvantaged neighborhoods had highest 30-day mortality (9% versus 3% White). Thirty-day SLE readmissions rivaled HF at 24%. Readmissio
Like
Comment
Share
